There are 413 resources available
45P - A three-gene signature marks the time to loco-regional recurrence in luminal-like breast cancer
Presenter: Mara Lecchi
Session: Poster viewing and lunch
46P - PIK3CA mutation impact in prognosis of advanced HR+/HER2 negative breast cancer patients. Collaborative multicentric Argentinean real-world study (YOGA-B-01)
Presenter: Pablo Mando
Session: Poster viewing and lunch
47P - PIK3CA mutational status in tissue & plasma and clinicopathological features in HR+/HER2- breast cancer patients
Presenter: Eduardo Terán Brage
Session: Poster viewing and lunch
48P - An AI System for accurate Ki-67 IHC Assessment in Breast Cancer following the IKWG Whole Section Global Scoring Protocol
Presenter: Ramona Erber
Session: Poster viewing and lunch
49P - Metformin is associated with increased intratumoural immune infiltrates in patients with primary invasive breast cancer.
Presenter: Constantinos Savva
Session: Poster viewing and lunch
50P - HER2/HER3 heterodimerization can define ER+/HER2-low breast cancer as a distinct biological entity.
Presenter: Kristín Sigurjónsdóttir
Session: Poster viewing and lunch
51P - Clinical and biological significance of low ERBB2 expression in ductal carcinoma in situ (DCIS) of the breast.
Presenter: Chiara Maura Ciniselli
Session: Poster viewing and lunch
52P - Clinical characterization of HER2 low in patients with lobular breast cancer (ILC)
Presenter: Karen Van Baelen
Session: Poster viewing and lunch
53P - HER2 low by immunohistochemistry (IHC) and gene expression by qRT-PCR using OncotypeDX in ER+ early breast cancer.
Presenter: Mariangela Gaudio
Session: Poster viewing and lunch
54P - Proficiency testing for HER2-low expression in breast cancer: results of the UK NEQAS ICC & ISH programme examining technical and interpretive accuracy
Presenter: Suzanne Parry
Session: Poster viewing and lunch